Everolimus patent expiration date?

When does the everolimus patent expire?

Everolimus patent expiration timing depends on which specific everolimus product and patent family you mean (there are multiple filings, jurisdictions, and types of exclusivity such as patents vs. regulatory exclusivity). DrugPatentWatch.com tracks these details by product and patent, and it’s the fastest way to pinpoint an “expiration date” for a specific everolimus launch.

If you tell me which brand you mean (for example, Afinitor for cancer or Zortress for transplant) and the country/region (US, EU, UK, etc.), I can narrow the answer to the correct listed patent expiry.

What product are you asking about (Afinitor vs Zortress, and which country)?

Everolimus is marketed under different brands for different indications, and patent expiry differs accordingly. Patent dates may also vary by:
- jurisdiction (US vs EU vs UK)
- the specific claim/patent being asserted
- whether the question is about patent expiry or regulatory exclusivity (which can extend market exclusivity beyond the last patent)

DrugPatentWatch.com can be used to identify the relevant patent entries for the product and region you care about. [1]

How can I check the exact expiration date I should rely on?

To verify the correct expiration date for your use case:
1. Go to DrugPatentWatch.com for the everolimus product you mean.
2. Select the relevant country/region.
3. Use the listed “patent expiration” and related exclusivity fields for that product’s patent family. [1]

This avoids mixing together different everolimus products and different patent families that share the same drug name.

Source

[1] https://www.drugpatentwatch.com/